Kahira Pharmaceuticals & Chemical Industries Balance Sheet Health
Financial Health criteria checks 5/6
Kahira Pharmaceuticals & Chemical Industries has a total shareholder equity of EGP745.6M and total debt of EGP184.4M, which brings its debt-to-equity ratio to 24.7%. Its total assets and total liabilities are EGP1.3B and EGP545.8M respectively. Kahira Pharmaceuticals & Chemical Industries's EBIT is EGP105.8M making its interest coverage ratio 262. It has cash and short-term investments of EGP221.5M.
Key information
24.7%
Debt to equity ratio
ج.م184.39m
Debt
| Interest coverage ratio | 262x |
| Cash | ج.م221.48m |
| Equity | ج.م745.64m |
| Total liabilities | ج.م545.83m |
| Total assets | ج.م1.29b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: CPCI's short term assets (EGP1.0B) exceed its short term liabilities (EGP343.6M).
Long Term Liabilities: CPCI's short term assets (EGP1.0B) exceed its long term liabilities (EGP202.2M).
Debt to Equity History and Analysis
Debt Level: CPCI has more cash than its total debt.
Reducing Debt: CPCI's debt to equity ratio has increased from 0% to 24.7% over the past 5 years.
Debt Coverage: CPCI's debt is well covered by operating cash flow (96.2%).
Interest Coverage: CPCI's interest payments on its debt are well covered by EBIT (262x coverage).